216394-11-5

Basic information

• Product Name: Benzenesulfonylchloride, 2-methoxy-4-methyl-
• Synonyms: Benzenesulfonyl chloride, 2-methoxy-4-methyl- (9CI)
• CAS NO: 216394-11-5
• Molecular Formula: C₈H₉ClO₃S
• Molecular Weight: 220.6733
• Product Categories: SULFONYLHALIDE
• Mol File: 216394-11-5.mol
• Article Data: 3

Chemical Properties

• Melting Point: 87-89°C
• Boiling Point: 319.9 °C at 760 mmHg
• Flash Point: 147.3 °C
• Appearance: /
• Density: 1.326 g/cm³
• Vapor Pressure: 0.000614mmHg at 25°C
• Refractive Index: 1.529
• Storage Temp.: 2-8°C
• BRN: 2838636
• CAS DataBase Reference: Benzenesulfonylchloride, 2-methoxy-4-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenesulfonylchloride, 2-methoxy-4-methyl-(216394-11-5)
• EPA Substance Registry System: Benzenesulfonylchloride, 2-methoxy-4-methyl-(216394-11-5)

Safety Data

• Statements: R34:Causes burns.
• Safety Statements: S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.; S36/37/39:Wear suitabl
• RIDADR: 3261
• HazardClass: 8
• PackingGroup: II
• Hazardous Substances Data: 216394-11-5(Hazardous Substances Data)

Usage

General Description

Benzenesulfonylchloride, 2-methoxy-4-methyl- is a chemical compound that is used in the synthesis of pharmaceuticals, dyes, and other organic compounds. It is an important intermediate in the production of various organic chemicals, including sulfa drugs, and is also used as a reagent in organic chemistry reactions. Benzenesulfonylchloride, 2-methoxy-4-methyl- is a versatile and useful compound with a wide range of applications in the chemical industry.

InChI:InChI=1/C8H9ClO3S/c1-6-3-4-8(13(9,10)11)7(5-6)12-2/h3-5H,1-2H3

Upstream product

• 27060-75-9 4-bromo-3-methylanisole 
• 59554-29-9 3-methoxy-toluene-4-sulfonic acid 

Downstream Products

• 478615-61-1 N-[4-(1,4-Diazepan-1-yl)-1-napthyl]-2-methoxy-4-methylbenzenesulfonamide, Hydrochloride 
• 199589-50-9 3-(1-{[(2-methoxy-4-methylphenyl)sulfonyl]carbamoyl}-1-(3,4-methylenedioxyphenyl)methyl)-1-methyl-1H-indole-6-carboxylic acid 
• 1443531-60-9 (7-methoxy-5-methyl-1-benzothiophen-2-yl)boronic acid 
• 1443531-59-6 1-[(2,2-diethoxyethyl)sulfanyl]-2-methoxy-4-methylbenzene 
• 1443530-05-9 4-{[4-amino-6-(methoxymethyl)-5-(7-methoxy-5-methyl-1-benzothiophen-2-yl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]methyl}piperazin-2-one 
• 83485-34-1 2-methoxy-4-methylbenzenethiol 
• 1198222-64-8 N-(5-((2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methoxy)-2-methylpentan-2-yl)-2-methoxy-4-methylbenzenesulfonamide 
• 862205-43-4 [1-(2-methoxy-4-methylbenzenesulfonylamino)-4-methyl-2-oxo-1,2-dihydropyridin-3-yl]acetic acid methyl ester 
• 1022957-66-9 tert-butyl 8-[(2-methoxy-4-methylphenyl)sulfonyl]-1-methyl-1,3,4,8-tetrahydro-2H-[1,4]oxazepino[6,7-e]indole-2-carboxylate 

Relevant articles and documents

NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA

The invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined in the description. The compounds of formula (I) are inhibitors of the YAP/TAZ-TEAD intera

Indole derivatives useful in therapy

The invention provides S-(+)-3-{1-(1,3-benzodioxol-5-yl)-2-[(2-methoxy-4-methylphenyl)sulfonylamino]-2-oxoethyl}-1-methyl-1H-indole-6-carboxylic acid, which is substantially free from its (R)-(?)-enantiomer, and pharmaceutically acceptable derivatives the